What is the current price and outlook for ISRG stock?

ISRG stock trades at **$522.04** pre-market on 30 Jan 2026. Analyst targets average **$618.52** and Meyka AI forecasts **$605.93** for one year; both imply mid-teens upside but valuation remains elevated.

How did ISRG perform in the latest earnings report?

Intuitive Surgical beat estimates with quarterly EPS **$2.53** and revenue **$2.87B**. Trailing EPS is **7.88** and net margin is **28.38%**, supporting growth-oriented ISRG stock narratives.

What are the main risks for ISRG stock investors?

Risks include high valuation (PE **64.41**), dependence on elective procedure volumes, potential reimbursement or regulatory changes, and insider selling. These can heighten short-term downside for ISRG stock.

Does Meyka AI give a rating for ISRG stock?

Yes. Meyka AI rates ISRG with a score of **74.62 out of 100 (B+, BUY)**, based on benchmark, sector, financial growth, key metrics, forecasts and analyst consensus.

US Stocks

$522.04 ISRG Intuitive Surgical (NASDAQ) pre-market 30 Jan 2026: AI surgical growth under watch

ByHuzaifa Zahoor January 30, 2026

ISRG stock opens pre-market at $522.04 on 30 Jan 2026 as investors weigh recent beats and AI-driven clinical tools. Intuitive Surgical, Inc. (ISRG) on NASDAQ remains a leader in robotic surgery and digital procedures, reporting trailing EPS 7.88 and a PE near 64.41. Volume sits at 1,851,332 shares versus an average of 2,114,059, and the stock trades between a 52-week low of $425.00 and high of $609.08. We examine earnings, valuation, technical signals, and how AI initiatives shape the outlook for ISRG stock